Recerca > Malalties cròniques, Cirurgia i Cures en Salut

Grup de recerca translacional vascular i renal

Nombre de publicacions
418
Cercador de publicacions
  • del Pino, MD; Andres, A; Bernabeu, AA; de Juan-Rivera, J; Fernandez, E; de Dios Garcia Diaz, Juan; Hernandez, D; Luño J; Fernandez, IM; Paniagua, J; Posada de la Pazk, Manuel; Rodriguez-Perez, JC; Santamaria, R; Torra, R; Ambros, JT; Vidau, P; Torregrosa, JV

    Fabry Nephropathy: An Evidence-Based Narrative Review

    KIDNEY & BLOOD PRESSURE RESEARCH 43 406-421. .

    [doi:10.1159/000488121]

  • Alcubierre, N; Castelblanco, E; Martinez-Alonso, M; Granado-Casas, M; Esquerda, A; Traveset, A; Martinez-Gonzalez, D; Franch-Nadal, J; Mauricio, D

    Vitamin D deficiency is associated with poorer satisfaction with diabetes-related treatment and quality of life in patients with type 2 diabetes: a cross-sectional study

    HEALTH AND QUALITY OF LIFE OUTCOMES 16 44-44. .

    [doi:10.1186/s12955-018-0873-3]

  • Bermudez-Lopez, M; Betriu À; Valdivielso, JM; Bretones Del Pino T; Arroyo, D; Fernandez, E

    Beyond the traditional lipid parameters in chronic kidney disease

    Nefrologia 38 109-113. .

    [doi:10.1016/j.nefro.2017.09.008]

  • Bozic M; Méndez-Barbero N; Gutiérrez-Muñoz C; Betriu A; Egido J; Fernández E; Martín-Ventura JL; Valdivielso JM; Blanco-Colio LM

    Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease

    Atherosclerosis 270 13-20. .

    [doi:10.1016/j.atherosclerosis.2018.01.011]

  • Carmona, A; Agura, ML; Luna-Ruiz, C; Buendia, P; Calleros, L; Garcia-Jerez, A; Rodriguez-Puyol, M; Arias, M; Arias-Guillen, M; de Arriba, G; Ballarin, J; Bernis, C; Fernandez, E; Garcia-Rebello, S; Mancha, J; del Peso, G; Perez, E; Poch, E; Portoles, JM; Rodriguez-Puyol, D; Synchez-Villanueva, R; Sarro, F; Torres, A; Martin-Malo, A; Aljama, P; Ramirez, R; Carracedo, J

    Markers of endothelial damage in patients with chronic kidney disease (vol 312, pg F673, 2017)

    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY 314 141-141. .

    [doi:10.1152/ajprenal.zh2-8409-corr.2017]

  • Rayego-Mateos, S; Rodrigues-Diez, R; Morgado-Pascual, JL; Valentijn, F; Valdivielso, JM; Goldschmeding, R; Ruiz-Ortega, M

    Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage

    Mediators of Inflammation 2018 8739473-8739473. .

    [doi:10.1155/2018/8739473]

  • Rivera K; Marzo C; Sans N; Ferrero A; Aldomà A; Schoenenberger JA; Galván L; Worner F

    Consensus is Possible: Initiation and Exchange of Oral Anticoagulants in Non-valvular Atrial Fibrillation, According to a Territorial Protocol in a Period of Time.

    European Cardiology 12 104-104. .

    [doi:10.15420/ecr.2017:23:13]

  • Borràs Sans M; Pérez-Fontán M; Martinez-Alonso M; Bajo A; Betriu À; Valdivielso JM; Fernández E

    The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease

    PLOS ONE 12 -. .

    [doi:10.1371/journal.pone.0186921]

  • Abajo M; Betriu À; Arroyo D; Gracia M; Del Pino MD; Martínez I; Valdivielso JM; Fernández E

    Mineral metabolism factors predict accelerated progression of common carotid intima-media thickness in chronic kidney disease: the NEFRONA study

    NEPHROLOGY DIALYSIS TRANSPLANTATION 32 1882-1891. .

    [doi:10.1093/ndt/gfw306]

  • Granado-Casas, M; Martinez-Alonso, M; Alcubierre, N; Ramirez-Morros, A; Hernandez, M; Castelblanco, E; Torres-Puiggros, J; Mauricio, D

    Decreased quality of life and treatment satisfaction in patients with latent autoimmune diabetes of the adult

    PeerJ 5 -. .

    [doi:10.7717/peerj.3928]

  • Valdivielso JM; Betriu A; Martinez-Alonso M; Arroyo D; Bermudez-Lopez M; Fernandez E

    Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound

    PLOS ONE 12 -. .

    [doi:10.1371/journal.pone.0186665]

  • Khan AUH; Allende-Vega, N; Gitenay, D; Gerbal-Chaloin, S; Gondeau, C; Vo, DN; Belkahla, S; Orecchioni, S; Talarico, G; Bertolini, F; Bozic, M; Valdivielso, JM; Bejjani, F; Jariel, I; Lopez-Mejia, IC; Fajas, L; Lecellier, CH; Hernandez, J; Daujat, M; Villalba, M

    The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 Pathway

    SCIENTIFIC REPORTS 7 10654-10654. .

    [doi:10.1038/s41598-017-10339-5]